Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations
Open Access
- 1 December 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Respiratory Research
- Vol. 12 (1), 99
- https://doi.org/10.1186/1465-9921-12-99
Abstract
Mutations in the bone morphogenetic protein receptor 2 (BMPR2) gene can lead to idiopathic pulmonary arterial hypertension (IPAH). This study prospectively screened for BMPR2 mutations in a large cohort of PAH-patients and compared clinical features between BMPR2 mutation carriers and non-carriers.Keywords
This publication has 25 references indexed in Scilit:
- Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Respiratory Journal, 2009
- Genetics of Pulmonary Arterial HypertensionSeminars in Respiratory and Critical Care Medicine, 2009
- Genetics and Genomics of Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2009
- A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertensionJournal of Medical Genetics, 2009
- Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 MutationAmerican Journal of Respiratory and Critical Care Medicine, 2008
- BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertensionHuman Mutation, 2006
- Genetics of Pulmonary Arterial Hypertension: Current and Future ImplicationsSeminars in Respiratory and Critical Care Medicine, 2005
- Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertensionJournal of Medical Genetics, 2004
- Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertensionThorax, 2004
- Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic TelangiectasiaNew England Journal of Medicine, 2001